4.8 Review

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Macrophage numbers in the marginal area of sarcomas predict clinical prognosis

Michinobu Umakoshi et al.

Summary: This study examined tumor-associated macrophages in the intratumoral and marginal areas of sarcomas and found that high levels of CD163- and CD204-positive macrophages in the marginal area were associated with poor disease-free survival. However, there was no significant association between macrophage numbers in the intratumoral area and disease-free survival.

SCIENTIFIC REPORTS (2023)

Review Immunology

Metabolism of tissue macrophages in homeostasis and pathology

Stefanie K. Wculek et al.

Summary: Cellular metabolism plays a crucial role in maintaining and regulating immune cell activities, with macrophages being essential for tissue homeostasis and potentially contributing to pathological conditions. Different macrophage populations in various organs have distinct functions, posing metabolic challenges for them to fulfill their roles in specific microenvironments.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Oncology

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Daniel P. Regan et al.

Summary: The combination of losartan and toceranib has significant clinical benefits in the treatment of osteosarcoma, as demonstrated in dog models.

CLINICAL CANCER RESEARCH (2022)

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Article Multidisciplinary Sciences

Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages

Kevin Christian M. Gulay et al.

Summary: Hemangiosarcoma (HSA) is a malignant tumor derived from endothelial cells. This study evaluated two mouse HSA cell lines as potential models for canine HSA. The ISOS-1 cell line was found to closely resemble canine HSA in terms of tumor morphology and gene expression patterns. Additionally, macrophages were identified as a major component of the tumor microenvironment in both ISOS-1 and canine HSA, and their expression of PD-L1 was associated with reduced T-cell presence in the tumor tissues. The findings suggest that macrophages play a significant role in immune evasion in HSA.

SCIENTIFIC REPORTS (2022)

Review Oncology

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

Kevin Pan et al.

Summary: CAR immunotherapy has achieved significant progress in hematological malignancies, but faces challenges in solid tumors. CAR NK cells and CAR macrophages have advantages and limitations. Developing CAR macrophages could be a strategy to overcome hurdles associated with CAR therapy in solid tumors.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Veterinary Sciences

Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy

Stephen Francis Proksch et al.

Summary: Human and canine sarcomas are challenging soft tissue malignancies with high recurrence and metastasis rates. In a study using genetically identical mice, intra-tumoral delivery of IL-2 and an anti-CD40 antibody showed promising curative responses. The same approach was then tested in domestic dogs with naturally occurring sarcomas, resulting in tumor regression and minimal side effects. These findings provide encouraging proof-of-concept data for developing immunotherapeutic strategies in both veterinary and human medicine.

VETERINARY AND COMPARATIVE ONCOLOGY (2022)

Article Oncology

A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy

Laura Marconato et al.

Summary: This study conducted a clinical trial on canine osteosarcoma using a vaccine as add-on therapy and found that the vaccine can effectively induce an immune response and improve treatment outcomes. This holds promising potential for future management of both human and canine osteosarcoma.

CANCERS (2022)

Review Biotechnology & Applied Microbiology

Macrophages as tools and targets in cancer therapy

Alberto Mantovani et al.

Summary: This review discusses the molecular mechanisms of macrophage reprogramming in the tumor microenvironment and provides an overview of macrophage-targeted therapies for cancer treatment.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Veterinary Sciences

Exploring the association of intratumoral immune cell infiltrates with histopathologic grade in canine mast cell tumors

Victoria R. Costa et al.

Summary: The presence of immune cells in tumor microenvironment may have an impact on the prognosis and treatment response of canine mast cell tumors. This study found that macrophages and PD-1+ cells were more common in high-grade ccMCTs, while the expression of CD3 and FOXP3 did not significantly differ among ccMCT grades. Further research is needed to understand the role of macrophages and PD-1+ cells in high-grade ccMCTs.

RESEARCH IN VETERINARY SCIENCE (2022)

Article Oncology

Reprogramming the Canine Glioma Microenvironment with Tumor Vaccination plus Oral Losartan and Propranolol Induces Objective Responses

Dylan T. Ammons et al.

Summary: This study evaluated a therapeutic protocol combining myeloid cell-targeted immunotherapy with tumor vaccination to overcome the immune barrier in malignant gliomas. The experiment conducted on a spontaneously occurring canine glioma model showed that this immunotherapy protocol induced tumor regression and improved overall survival time.

CANCER RESEARCH COMMUNICATIONS (2022)

Article Veterinary Sciences

The Effect of Arginase on Canine T-Lymphocyte Functions and its Modulation by All-Trans Retinoid Acid (ATRA) in Canine Monocyte-Derived Macrophages

Aimee M. Soileau et al.

Summary: Significant progress has been made in cancer treatment over the past 20 years due to a better understanding of the immune response to tumors. This study examines the potential role of all-trans retinoic acid (ATRA) in modulating cancer immunity in dogs. The results suggest that ATRA can decrease the production of pro-cancer substances by macrophages and inhibit the activity of critical anti-cancer immune cells in dogs. Further research is needed to determine the direct link between ATRA treatment and immune cell response in dogs.

VETERINARY SCIENCES (2022)

Review Chemistry, Medicinal

Potential PET tracers for imaging of tumor-associated macrophages

Bruna Fernandes et al.

Summary: The increasing incidence of cancer is a challenging problem in healthcare. Infiltration of tumor-associated macrophages (TAMs) is correlated with poor prognosis. Non-invasive imaging techniques like PET could provide a better understanding of TAMs in cancer and aid in individualized immunotherapy.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2022)

Article Veterinary Sciences

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines

Jordan Ayers et al.

Summary: The study applied single-cell transcriptome analysis to 4 canine osteosarcoma cell lines, revealing significant heterogeneity in gene transcription expression patterns and providing important data for further understanding the pathogenesis of canine osteosarcoma.

JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2021)

Article Agriculture, Dairy & Animal Science

Correlation between Tumour Associated Macrophage (TAM) Infiltration and Mitotic Activity in Canine Soft Tissue Sarcomas

Riccardo Finotello et al.

Summary: Tumour-associated macrophages (TAMs) are identified and counted in canine soft tissue sarcomas (STSs), showing a positive correlation between TAM numbers and histologic grade. TAMs are more abundant in higher grade STSs, leading to a potential risk of misdiagnosis as histiocytic sarcoma by pathologists.

ANIMALS (2021)

Article Neurosciences

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Ana Rita Pombo Antunes et al.

Summary: By utilizing single-cell RNA sequencing and CITE-seq, this study reveals the complexity of the immune landscape in glioblastomas, including conserved populations of dendritic cells and macrophages. The results indicate that microglia-derived tumor-associated macrophages dominate in newly diagnosed tumors, but are replaced by monocyte-derived TAMs in recurrences.

NATURE NEUROSCIENCE (2021)

Article Veterinary Sciences

Hematologic and clinical characteristics of dogs with circulating macrophage-like cells

Hiroyuki Mochizuki et al.

Summary: This study retrospectively described hematologic and clinical characteristics of dogs with circulating macrophage-like (ML) cells in peripheral blood. Dogs with ML cells often exhibited severe inflammatory conditions or histiocytic and non-histiocytic neoplasia. The presence of ML cells was associated with shorter median survival time and increased occurrence of death/euthanasia within 1 month.

VETERINARY CLINICAL PATHOLOGY (2021)

Article Multidisciplinary Sciences

The impact of damage-associated molecules released from canine tumor cells on gene expression in macrophages

Shotaro Eto et al.

Summary: Dying or damaged cells releasing intracellular components can lead to immune reactions that may cause inflammation and cancer development. Inhibition of prostaglandin E2 (PGE2) production can induce the expression of tumor necrosis factor (Tnf) in necrotic tumor cells. Comprehensive RNA-seq analysis revealed three categories of genes induced by damage-associated molecules.

SCIENTIFIC REPORTS (2021)

Review Oncology

The Role of Macrophages in Cancer Development and Therapy

Ewa Cendrowicz et al.

Summary: Tumor-Associated Macrophages (TAMs) play a crucial role in tumor development and are potential targets for cancer therapy due to their influence on immunity and tumor microenvironment.

CANCERS (2021)

Article Oncology

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Reetta Virtakoivu et al.

Summary: The study revealed the unique role of the Clever-1 receptor in suppressing adaptive immune cells in the tumor microenvironment, suggesting that targeting this receptor may promote intratumoral proinflammatory responses and have potential therapeutic effects for patients with metastatic cancer.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Gulam A. Manji et al.

Summary: This study evaluated the safety and tolerability of combination therapy with pexidartinib and sirolimus in soft tissue sarcomas, showing promising clinical benefit and supporting further investigation of this treatment approach.

CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

The Role of Tumor Associated Macrophages (TAMs) in Cancer Pro-gression, Chemoresistance, Angiogenesis and Metastasis-Current Status

Siva Dallavalasa et al.

Summary: TAMs in the tumor microenvironment play a significant role in promoting cancer cell metastasis and influencing angiogenesis, as well as inducing multidrug resistance.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Pathology

Immunohistochemical evaluation of immune cell infiltration in canine gliomas

Gregory A. Krane et al.

Summary: Immune evasion is crucial in the pathogenesis of glioma, with canine glioma showing a robust immune cell infiltrate. Different numbers of specific cells were found in low-grade and high-grade gliomas, suggesting potential therapeutic targets for repolarization of macrophages or Treg interference in canine glioma.

VETERINARY PATHOLOGY (2021)

Article Pathology

Prognostic histopathologic features of canine glial tumors

Joshua L. Merickel et al.

Summary: Canine gliomas are relatively common tumors in aged dogs, and the dog is proving to be a useful translational model for humans with brain tumors. Analysis of tumor biopsies and whole-brain data revealed that dogs with astrocytic tumors lived longer than those with oligodendroglial or undefined tumor types.

VETERINARY PATHOLOGY (2021)

Article Agriculture, Dairy & Animal Science

Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas

Sergio Vazquez et al.

Summary: This study investigated the relationship between macrophage infiltrates and histological grade and immunophenotype in cases of canine lymphoma. Results showed that high-grade and B-cell lymphomas had the highest number of macrophages, with a predominant M2 phenotype. The findings suggest a complex interaction between macrophages, tumor behavior, and immune response in canine lymphoma.

ANIMALS (2021)

Review Chemistry, Medicinal

Small-molecule CSF1R kinase inhibitors; review of patents 2015-present

William A. Denny et al.

Summary: In the past 5 years, there has been a significant increase in activity surrounding small molecule inhibitors of CSF1R, driven by the approval of pexidartinib in 2019. The field has seen surprising diversity in chemical classes and potential disease states targeted by these inhibitors, including cancer, arthritis, and cytokine storm syndromes. The range of potential utilities of CSF1R inhibitors has also expanded to include diseases like dementia, ulcerative colitis/Crohn's disease, rheumatoid arthritis inflammation, and fibrosis.

EXPERT OPINION ON THERAPEUTIC PATENTS (2021)

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Hematology

The Role of Tumor-Associated Macrophages in Leukemia

Yueyang Li et al.

ACTA HAEMATOLOGICA (2020)

Article Multidisciplinary Sciences

Cellular backpacks for macrophage immunotherapy

C. Wyatt Shields et al.

SCIENCE ADVANCES (2020)

Review Cell Biology

Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy

Kamila Bendickova et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Multidisciplinary Sciences

Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells

Silke Eisinger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Veterinary Sciences

Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma

Sita S. Withers et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2019)

Review Immunology

Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them

M. A. F. Yahaya et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2019)

Review Immunology

Adaptation and memory in immune responses

Gioacchino Natoli et al.

NATURE IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages

Yanxian Feng et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

The Ontogeny of Monocyte Subsets

Anja A. Wolf et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

F. Zhang et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

The Dark Side of IFN-: Its Role in Promoting Cancer Immunoevasion

Marija Mojic et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Veterinary Sciences

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

T. Laver et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2018)

Review Developmental Biology

The hematopoietic stem cell niche: from embryo to adult

Xin Gao et al.

DEVELOPMENT (2018)

Review Oncology

Naturally Occurring Canine Glioma as a Model for Novel Therapeutics

Molly E. Hubbard et al.

CANCER INVESTIGATION (2018)

Article Medicine, Research & Experimental

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Hui-Ming Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Veterinary Sciences

Tumor-associated macrophage is correlated with survival and SOCS expression in canine mammary carcinoma

Carlos H. C. Vieira-Filho et al.

PESQUISA VETERINARIA BRASILEIRA (2018)

Review Oncology

Distant Relations: Macrophage Functions in the Metastatic Niche

Geneva R. Doak et al.

TRENDS IN CANCER (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo MR Imaging of Tumor-Associated Macrophages: The Next Frontier in Cancer Imaging

Runze Yang et al.

MAGNETIC RESONANCE INSIGHTS (2018)

Article Veterinary Sciences

Immune regulation of canine tumour and macrophage PD-L1 expression

G. Hartley et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2017)

Review Immunology

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

Elias J. Sayour et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2017)

Article Oncology

Defining the Value of a Comparative Approach to Cancer Drug Development

Amy K. LeBlanc et al.

CLINICAL CANCER RESEARCH (2016)

Review Oncology

Coley's Lessons Remembered: Augmenting Mistletoe Therapy

Maurice Orange et al.

INTEGRATIVE CANCER THERAPIES (2016)

Article Microbiology

Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells

Ryan G. Gaudet et al.

MICROBIOLOGY SPECTRUM (2016)

Review Veterinary Sciences

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

C. Khanna et al.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)

Article Veterinary Sciences

Prognostic value of tumour-associated macrophages in canine mammary tumours

T. Raposo et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2014)

Review Multidisciplinary Sciences

Macrophage biology in development, homeostasis and disease

Thomas A. Wynn et al.

NATURE (2013)

Article Biochemical Research Methods

Systematic validation of specific phenotypic markers for in vitro polarized human macrophages

C. A. Ambarus et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2012)

Review Medicine, Research & Experimental

Tumour macrophages as potential targets of bisphosphonates

Thea L. Rogers et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2011)

Article Oncology

Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs

Scott Hafeman et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

Article Oncology

Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses

Joseph L. Sottnik et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

Article Multidisciplinary Sciences

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Lee A. Honigberg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Immunology

Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder

Timothy P. Kresowik et al.

IMMUNOTHERAPY (2009)